RiMINI – the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-016-1205-8
Published Online: 2016-02-29
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schulz, Christian
Schütte, Kerstin
Kropf, Siegfried
Schmitt, Friedhelm C.
Vasapolli, Riccardo
Kliegis, Leon M.
Riegger, Antonia
Malfertheiner, Peter